Ignite Creation Date:
2024-05-05 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 9:37 AM
Study NCT ID:
NCT00556699
Status:
COMPLETED
Last Update Posted:
2014-03-20
First Post:
2007-11-09
Brief Title:
A Study of SGN-40 in Combination With Rituximab in Patients With CD20-Positive Follicular and Marginal Zone B-Cell Non-Hodgkins Lymphoma
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Organization Data
Organization:
Genentech Inc
Class:
INDUSTRY
Study ID:
ACF4325g
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genentech Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Seagen Inc | INDUSTRY |